Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
benzoin	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Right	O
heart	O
catheterization	O
and	O
trial	O
of	O
inotropes	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
Right	O
heart	O
catheterization:	O
___	O
Placement	O
of	O
___	O
catheter:	O
___	O
___	O
line	O
placement	O
History	O
of	O
Present	O
Illness:	O
Mr.	O
___	O
is	O
a	O
___	O
y/o	O
gentleman	O
with	O
a	O
history	O
of	O
CAD,	O
infarct	O
related	O
cardiomyopathy,	O
hypertension,	O
dyslipidemia,	O
and	O
pre-diabetes	O
who	O
presents	O
to	O
the	O
CCU	O
after	O
right	O
heart	O
catheterization	O
procedure/PA	O
cath	O
placement	O
for	O
trial	O
of	O
inotropes/tailored	O
therapy.	O
Over	O
the	O
past	O
3	O
months,	O
the	O
patient	O
has	O
been	O
increasingly	O
symptomatic	O
from	O
his	O
heart	O
failure	O
despite	O
multiple	O
changes	O
to	O
his	O
medications.	O
There	O
have	O
been	O
multiple	O
discussions	O
as	O
an	O
outpatient	O
regarding	O
a	O
possible	O
plan	O
of	O
care	O
that	O
includes	O
either	O
inotropes	O
or	O
the	O
placement	O
of	O
an	O
LVAD.	O
He	O
has	O
agreed	O
for	O
a	O
RHC	O
and	O
a	O
trial	O
of	O
inotropes.	O
He	O
has	O
consistently	O
refused	O
the	O
possibility	O
of	O
LVAD.	O
His	O
symptoms	O
over	O
the	O
past	O
3	O
months	O
include	O
decreased	O
appetite,	O
poor	O
PO	O
intake,	O
fatigue,	O
lack	O
of	O
energy	O
and	O
general	O
malaise.	O
Past	O
Medical	O
History:	O
Cardiac	O
1.	O
Stage	O
D	O
mixed	O
partially	O
infarct-related	O
cardiomyopathy.	O
A.	O
___	O
totally	O
occluded	O
RCA,	O
70%	O
MLCX	O
stented,	O
90%	O
D1	O
stented.	O
B.	O
Sustained	O
VT	O
___,	O
repeat	O
cath,	O
collateralized	O
RCA,	O
patent	O
stents,	O
EF	O
significantly	O
decreased	O
at	O
that	O
time.	O
C.	O
___,	O
___	O
chest	O
pain,	O
cardiogenic	O
shock,	O
anterolateral	O
MI,	O
100%	O
mid	O
LAD	O
occlusion	O
3	O
x	O
15	O
BMS	O
jailing	O
D1,	O
LCX	O
no	O
disease,	O
severe	O
PHTN,	O
EF	O
15%	O
at	O
that	O
time.	O
D.	O
___	O
___	O
Status	O
post	O
CABG	O
x4	O
with	O
Dr.	O
___.	O
___	O
to	O
LAD,	O
SVG	O
to	O
PDA,	O
ramus	O
and	O
diagonal.	O
2.	O
Status	O
post	O
___	O
ICD	O
(___)	O
with	O
CRT	O
optimization	O
___,	O
AV	O
delay	O
optimized	O
according	O
to	O
mitral	O
inflow	O
pattern	O
to	O
120	O
milliseconds,	O
VV	O
offset	O
optimized	O
according	O
to	O
aortic	O
outflow	O
pattern.	O
Full	O
results	O
of	O
this	O
are	O
in	O
scanned	O
records	O
3.	O
Hypertension,	O
remote.	O
4.	O
Mixed	O
dyslipidemia.	O
5.	O
ICH	B-Intracranial_haemorrhage
on	O
Coumadin	O
___	O
for	O
cardiomyopathy.	O
6.	O
Sustained	O
VT	O
___,	O
but	O
not	O
inducible	O
on	O
EP	O
study.	O
7.	O
Type	O
2	O
diabetes.	O
Other	O
1.	O
BPH	O
2.	O
Depression	O
3.	O
Hypothyroidism	O
4.	O
History	O
of	O
babesiosis	O
Social	O
History:	O
___	O
Family	O
History:	O
No	O
family	O
history	O
of	O
premature	O
coronary	O
disease	O
or	O
sudden	O
death.	O
Father	O
died	O
of	O
throat	O
cancer	O
at	O
age	O
___,	O
mother	O
died	O
of	O
unknown	O
cause	O
at	O
age	O
___.	O
Does	O
not	O
speak	O
to	O
sister	O
and	O
brother.	O
Physical	O
Exam:	O
>>	O
ADMITTING	O
PHYSICAL	O
EXAM:	O
VS:	O
T=	O
98.1	O
BP=	O
85/67	O
HR=	O
96	O
V	O
paced	O
with	O
PVC's	O
RR=	O
16	O
O2	O
sat=	O
95%	O
on	O
RA	O
General:	O
Alert,	O
oriented,	B-Delirium
in	O
no	O
acute	O
distress	O
HEENT:	O
normocephalic,	O
atraumatic,	O
MMM,	O
PERRL	O
Neck:	O
PA	O
cath	O
in	O
left	O
neck	O
CV:	O
RRR,	O
faint	O
systolic	O
murmur	O
heart	O
best	O
at	O
apex.	O
No	O
gallops	O
or	O
rubs.	O
Lungs:	O
Mild	O
bilateral	O
crackles	O
in	O
inferior	O
___	O
of	O
lung	O
fields.	O
No	O
wheezes	O
or	O
rhonchi.	O
Abdomen:	O
soft,	O
nontender,	O
normal	O
bowel	O
sounds	O
Ext:	O
upper	O
extremities	O
are	O
warm	O
with	O
<	O
1	O
sec	O
cap	O
refil.	O
No	O
cyanosis	O
or	O
clubbing.	O
No	O
lower	O
extremity	O
edema.	O
Pulses:	O
2+	O
bilateral	O
DP	O
and	O
radial	O
pulses	O
.	O
>>	O
DISCHARGE	O
PHYSICAL	O
EXAM:	O
Temp	O
36.5Â°C	O
HR:	O
99	O
BP:	O
96/64(71)	O
RR:	O
16	O
SpO2:	O
95%	O
General:	O
Alert,	O
oriented,	B-Delirium
in	O
no	O
acute	O
distress	O
HEENT:	O
normocephalic,	O
atraumatic,	O
MMM,	O
PERRL	O
Neck:	O
Supple,	O
no	O
cervical	O
lymphadenopathy	O
appreciated.	O
CV:	O
Soft	O
systolic	O
murmur	O
heart	O
best	O
at	O
apex.	O
No	O
gallops	O
or	O
rubs.	O
Lungs:	O
CTABL.	O
No	O
rales,	O
wheezes	O
or	O
rhonchi.	O
Abdomen:	O
Soft,	O
NT/ND.	O
BS+	O
Ext:	O
Warm	O
to	O
touch.	O
PICC	O
in	O
right	O
elbow.	O
Pulses:	O
1+	O
bilateral	O
DP	O
and	O
radial	O
pulses.l	O
Pertinent	O
Results:	O
>>	O
ADMISSION	O
LABS	O
___	O
10:50AM	O
BLOOD	O
WBC-8.5	O
RBC-4.16*	O
Hgb-11.6*	O
Hct-36.7*	O
MCV-88	O
MCH-27.9	O
MCHC-31.6	O
RDW-16.5*	O
Plt	O
___	O
___	O
10:50AM	O
BLOOD	O
___	O
PTT-25.8	O
___	O
___	O
10:50AM	O
BLOOD	O
Glucose-104*	O
UreaN-27*	O
Creat-1.5*	O
Na-141	O
K-3.6	O
Cl-101	O
HCO3-25	O
AnGap-19	O
___	O
04:34AM	O
BLOOD	O
ALT-130*	O
AST-125*	O
LD(LDH)-217	O
AlkPhos-39*	O
TotBili-0.7	O
___	O
03:50PM	O
BLOOD	O
Calcium-8.8	O
Phos-3.6#	O
Mg-2.1	O
.	O
RIGHT	O
HEART	O
CATHETERIZATION	O
___	O
Blood	O
Oximetry	O
Information	O
Baseline	O
(room	O
air)	O
Time	O
Site	O
Hgb	O
___	O
Content	O
gm/dL	O
%	O
ml/dl	O
01:46	O
___	O
SVC	O
11.60	O
56	O
8.83	O
02:04	O
___	O
PA	O
11.60	O
51	O
8.05	O
02:04	O
___	O
AO	O
(imputed)	O
11.60	O
94	O
14.83	O
02:05	O
___	O
PA	O
11.60	O
51	O
8.05	O
Arterial	O
oxygen	O
saturation	O
imputed	O
from	O
finger	O
oxymetry	O
Cardiac	O
Output	O
Results	O
Phase	O
Fick	O
Fick	O
C.O.	O
C.I.	O
L/min	O
LPM/m2	O
Baseline	O
3.98	O
1.84	O
Using	O
assumed	O
VO2	O
of	O
125	O
mL/min/m2	O
Hemodynamic	O
Measurements	O
(mmHg)	O
Baseline	O
Site	O
___	O
___	O
End	O
Mean	O
A	O
Wave	O
V	O
Wave	O
HR	O
RA	O
9	O
12	O
12	O
77	O
RV	O
53	O
11	O
83	O
PCW	O
24	O
27	O
29	O
72	O
PA	O
53	O
27	O
37	O
91	O
Resistance	O
Results	O
Phase	O
PVR	O
PVR	O
dsc-5	O
___	O
Baseline	O
261	O
3.27	O
Assessment	O
&	O
Recommendations	O
1.	O
Low	O
cardiac	O
index	O
and	O
systemic	O
arterial	O
hypotension	O
meeting	O
criteria	O
for	O
cardiogenic	O
shock.	O
2.	O
Moderate	O
pulmonary	O
hypertension.	O
3.	O
Moderate-severe	O
elevation	O
of	O
PCW	O
consistent	O
with	O
clinical	O
diagnosis	O
of	O
LV	O
diastolic	O
heart	O
failure.	O
4.	O
Right	O
ventricular	O
diastolic	O
dysfunction.	O
5.	O
Findings	O
discussed	O
by	O
telephone	O
with	O
Dr.	O
___.	O
SGC	O
secured	O
in	O
place	O
for	O
tailored	O
therapy	O
in	O
the	O
CCU.	O
6.	O
Reinforce	O
secondary	O
preventative	O
measures	O
against	O
CAD,	O
LVSD	O
and	O
diastolic	O
heart	O
failure.	O
7.	O
No	O
right	O
internal	O
jugular	O
vein	O
was	O
visible	O
on	O
ultrasound	O
imaging.	O
On	O
further	O
questioning,	O
the	O
patient	O
reported	O
H/O	O
failed	O
attempts	O
at	O
RIJ	O
access	O
for	O
dialysis	O
catheters.	O
Would	O
recommend	O
avoiding	O
any	O
attempts	O
at	O
right	O
internal	O
jugular	O
venous	O
access	O
in	O
the	O
future	O
as	O
the	O
likelihood	O
of	O
success	O
is	O
minimal.	O
PACEMAKER	O
INTERROGATION	O
___	O
Presenting	O
rhythm:	O
___	O
paced	O
@	O
100	O
bpm	O
Intrinsic	O
Rhythm:	O
AS-VS	O
@	O
90	O
bpm	O
Programmed	O
Mode:	O
DDD	O
60-120,	O
AVD	O
140	O
Battery	O
Voltage:	O
3.1V	O
RA	O
lead	O
Model	O
Brand/Number:	O
___	O
___	O
CapSureFix	O
Novus	O
/	O
___	O
Intrinsic	O
amplitude:	O
1.1	O
mV	O
Pacing	O
impedance:	O
361	O
ohms	O
Pacing	O
threshold:	O
1.5	O
V	O
@	O
0.4	O
ms	O
%	O
Pacing:	O
APVS	O
<0.1%,	O
AP-VP	O
1.7%	O
RV	O
lead	O
Model	O
Brand/Number:	O
___	O
___	O
___	O
Secure	O
/	O
TD___	O
Intrinsic	O
amplitude:	O
2.9	O
mV	O
Pacing	O
impedance:	O
399	O
ohms	O
Pacing	O
threshold:	O
0.25	O
V	O
@	O
0.4	O
ms	O
%pacing:	O
___	O
94.3%,	O
___	O
1.7%	O
LV	O
lead	O
Model	O
Brand/Number:	O
___	O
___	O
Attain	O
/	O
___	O
Intrinsic	O
amplitude:	O
2.9	O
mV	O
Pacing	O
impedance:	O
475	O
ohms	O
Pacing	O
threshold:	O
1.75	O
V	O
@	O
1	O
ms	O
%pacing:	O
___	O
94.3%,	O
___	O
1.7%	O
Diagnostic	O
information:	O
-VT	O
+	O
Fast	O
VT	O
therapies	O
set	O
to	O
off	O
-VF	O
rate	O
>188	O
bpm,	O
ATP	O
followed	O
by	O
25	O
J,	O
35J	O
x	O
5	O
-Defibrillation	O
threshold	O
RV	O
36	O
ohms,	O
SVC	O
45	O
ohms	O
-One	O
brief	O
episode	O
of	O
atrial	O
tachycardia	O
x	O
1	O
second	O
@	O
120	O
bpm,	O
___	O
at	O
1:02	O
pm	O
-<1%	O
AT/AF	O
-No	O
therapies	O
given	O
Programming	O
changes:	O
none	O
Summary:	O
Normal	O
device	O
function,	O
brief	O
episode	O
of	O
atrial	O
tachycardia	O
noted	O
DISCHARGE	O
LABS:	O
___	O
05:26AM	O
BLOOD	O
WBC-9.2	O
RBC-3.93*	O
Hgb-10.6*	O
Hct-34.1*	O
MCV-87	O
MCH-27.1	O
MCHC-31.2	O
RDW-15.7*	O
Plt	O
___	O
___	O
05:27AM	O
BLOOD	O
Glucose-111*	O
UreaN-33*	O
Creat-1.3*	O
Na-138	O
K-3.5	O
Cl-98	O
HCO3-26	O
AnGap-18	O
___	O
05:27AM	O
BLOOD	O
Phos-4.7*	O
Mg-2.1	O
Brief	O
Hospital	O
Course:	O
Mr.	O
___	O
is	O
a	O
___	O
y/o	O
gentleman	O
with	O
a	O
history	O
of	O
CAD,	O
infarct	O
related	O
cardiomyopathy,	O
hypertension,	O
dyslipidemia,	O
and	O
diabetes	O
who	O
presents	O
to	O
the	O
CCU	O
after	O
right	O
heart	O
catheterization	O
procedure/PA	O
cath	O
placement	O
for	O
trial	O
of	O
inotropes/tailored	O
therapy.	O
.	O
>>	O
ACTIVE	O
ISSUES:	O
#	O
Heart	O
failure	O
with	O
depressed	O
EF	O
secondary	O
to	O
ischemic	O
cardiomyopathy	O
Pt	O
presented	O
to	O
the	O
hospital	O
as	O
a	O
planned	O
admission	O
on	O
___	O
for	O
a	O
right	O
heart	O
catherization	O
and	O
trial	O
of	O
inotropes.	O
PA	O
catheter	O
was	O
also	O
placed	O
on	O
___	O
for	O
monitoring	O
of	O
cardiac	O
indices	O
while	O
inotropic	O
therapy	O
was	O
started.	O
Cardiac	O
Index	O
measured	O
during	O
the	O
RHC	O
was	O
1.8	O
with	O
a	O
cardiac	O
output	O
of	O
3.98	O
L/min.	O
The	O
patient	O
was	O
brought	O
to	O
the	O
CCU	O
after	O
the	O
catheterization	O
procedure	O
where	O
milrinone	O
0.26-0.5mcg/kg/min	O
IV	O
was	O
started	O
with	O
plans	O
to	O
titrate	O
to	O
a	O
cardiac	O
index	O
of	O
2.0.	O
Pacemaker	O
interrogation	O
was	O
also	O
done	O
on	O
___	O
with	O
results	O
shown	O
above.	O
Patient	O
was	O
restarted	O
on	O
his	O
home	O
meds	O
with	O
the	O
exception	O
of	O
metoprolol	O
which	O
had	O
been	O
held	O
1	O
week	O
prior	O
due	O
to	O
fatigue.	O
On	O
___,	O
Mr.	O
___	O
was	O
given	O
an	O
additional	O
dose	O
of	O
torsemide	O
40mg	O
(total	O
80mg)	O
due	O
to	O
inadequate	O
diuresis.	O
His	O
cardiac	O
index	O
ranged	O
between	O
2.0	O
and	O
2.1	O
on	O
milrinone	O
0.5mcg/kg/min	O
IV	O
and	O
he	O
seemed	O
to	O
be	O
tolerating	O
therapy	O
well.	O
Later	O
in	O
the	O
day,	O
due	O
to	O
continued	O
difficulty	O
with	O
diuresis,	O
Mr.	O
___	O
was	O
given	O
___	O
120mg	O
IV	O
bolus	O
and	O
subsequently	O
started	O
on	O
Lasix	O
10mg/hr	O
continuous	O
drip.	O
Over	O
the	O
next	O
___	O
hours,	O
he	O
put	O
out	O
1,325mL	O
with	O
716mL	O
intake.	O
On	O
___,	O
Mr.	O
___	O
continued	O
to	O
do	O
well	O
with	O
CI	O
2.4	O
and	O
CO	O
5.2L.	O
He	O
also	O
received	O
a	O
PICC	O
line	O
for	O
anticipation	O
of	O
home	O
inotropic	O
therapy.	O
Titration	O
of	O
his	O
diuresis	O
was	O
done	O
in	O
accordance	O
to	O
PCWP	O
pressure	O
goals	O
of	O
___.	O
Once	O
goal	O
pressures	O
met,	O
PA	O
cath	O
was	O
discontinued	O
and	O
patient	O
it	O
was	O
attempted	O
to	O
keep	O
patient	O
in	O
fluid	O
balance.	O
Home	O
infusion	O
care	O
with	O
milrinone	O
was	O
done	O
prior	O
to	O
discharge,	O
with	O
PICC	O
line	O
teaching	O
and	O
infusion	O
teaching	O
at	O
bedside	O
with	O
patient	O
and	O
his	O
family.	O
After	O
an	O
episode	O
of	O
symptomatic	O
VT	O
(which	O
self	O
terminated)	O
on	O
___	O
patient	O
expressed	O
a	O
desire	O
to	O
minimize	O
arrhythmia	O
symptoms,	O
so	O
the	O
decision	O
was	O
made	O
to	O
discontinue	O
milrinone	O
and	O
to	O
be	O
sent	O
home	O
that	O
day	O
on	O
amiodarone.	O
Education	O
regarding	O
dietary	O
medication	O
compliance	O
continued.	O
#	O
CAD	O
s/p	O
infarction	O
and	O
PCI/CABG	O
x4	O
Mr.	O
___	O
was	O
maintained	O
on	O
his	O
home	O
medications	O
of	O
aspirin	O
81mg	O
PO	O
daily,	O
atorvastatin	O
80mg	O
PO	O
daily,	O
nitroglycerin	O
0.4mg	O
SL	O
PRN	O
chest	O
pain,	O
and	O
fenofibrate	O
145mg	O
PO	O
daily	O
for	O
the	O
duration	O
of	O
the	O
hospital	O
stay.	O
At	O
no	O
point	O
did	O
he	O
complain	O
of	O
any	O
chest	O
pain	O
or	O
discomfort.	O
Admission	O
EKG	O
did	O
not	O
show	O
any	O
new	O
ST	O
segment	O
changes	O
or	O
T	O
wave	O
abnormalities.	O
#	O
Status	O
post	O
___	O
ICD	O
(___)	O
with	O
CRT	O
optimization	O
___	O
Mr.	O
___	O
pacemaker	O
was	O
interrogated	O
during	O
this	O
admission	O
with	O
the	O
results	O
shown	O
above.	O
While	O
on	O
milrinone	O
therapy,	O
he	O
experienced	O
frequent	O
VPBs	O
as	O
seen	O
on	O
telemetry.	O
Goals	O
of	O
care	O
discussion	O
with	O
the	O
patient	O
and	O
his	O
family	O
was	O
done	O
during	O
admission,	O
and	O
was	O
noted	O
that	O
he	O
will	O
go	O
home	O
on	O
milrinone	O
with	O
his	O
ICD	O
sensing	O
turned	O
off.	O
On	O
the	O
AM	O
of	O
___	O
-	O
patient	O
underwent	O
a	O
short	O
episode	O
of	O
sustained	O
VT	O
which	O
produced	O
lightheadedness	O
and	O
vision	B-Visual_impairment
changes.	B-Visual_impairment
VT	O
self	O
terminated	O
and	O
did	O
not	O
require	O
external	O
intervention.	O
However,	O
the	O
episode	O
was	O
distressing,	O
and	O
Mr	O
___	O
initially	O
expressed	O
a	O
desire	O
to	O
turn	O
ICD	O
back	O
on.	O
After	O
a	O
family	O
meeting,	O
however,	O
it	O
was	O
decided	O
to	O
keep	O
his	O
ICD	O
off,	O
continue	O
DNR/DNI	O
and	O
to	O
withdraw	O
his	O
milrinone	O
which	O
was	O
thought	O
to	O
be	O
contributing	O
to	O
his	O
arrhytmia/ectopy.	O
He	O
was	O
discharged	O
on	O
seven	O
days	O
of	O
amiodarone	O
for	O
arrhytmia	O
suppression	O
during	O
the	O
milrinone	O
washout	O
period.	O
.	O
>>	O
CHRONIC	O
ISSUES:	O
#	O
Pre-diabetes:	O
During	O
this	O
hospital	O
admission,	O
Mr.	O
___	O
blood	O
glucose	O
ranged	O
from	O
98	O
to	O
184.	O
He	O
was	O
maintained	O
on	O
a	O
regular	O
diet,	O
2g	O
sodium,	O
heart	O
healthy.	O
His	O
most	O
recent	O
HbA1c	O
is	O
from	O
___	O
and	O
was	O
5.9.	O
.	O
#	O
BPH:	O
Mr.	O
___	O
was	O
maintained	O
on	O
his	O
home	O
medications	O
of	O
finasteride	O
5mg	O
PO	O
daily	O
and	O
tamsulosin	O
0.4mg	O
PO	O
QHS.	O
He	O
did	O
not	O
complain	O
of	O
urinary	O
frequency,	O
urgency,	O
or	O
hesitation	O
during	O
this	O
admission.	O
.	O
#	O
Depression:	O
Mr.	O
___	O
was	O
maintained	O
on	O
his	O
home	O
medication	O
of	O
venlafaxine	O
XR	O
225mg	O
PO	O
daily.	O
He	O
did	O
experience	O
brief	O
episodes	O
of	O
depressed	O
mood	O
where	O
he	O
expressed	O
the	O
desire	O
to	O
leave	O
the	O
hospital	O
with	O
wishes	O
that	O
"if	O
he	O
was	O
going	O
to	O
die,	O
he	O
did	O
not	O
want	O
to	O
die	O
in	O
a	O
hospital."	O
His	O
mood	O
usually	O
improved	O
after	O
a	O
few	O
hours	O
and	O
he	O
was	O
compliant	O
with	O
the	O
CCU	O
team's	O
plan.	O
.	O
#	O
Hypothyroidism:	O
Mr.	O
___	O
was	O
maintained	O
on	O
his	O
home	O
medication	O
of	O
levothyroxine	O
sodium	O
137mcg	O
PO	O
daily.	O
His	O
most	O
recent	O
TSH	O
was	O
6.5	O
on	O
___.	O
.	O
#	O
Gout:	O
Mr.	O
___	O
was	O
maintained	O
on	O
his	O
home	O
medications	O
of	O
allopurinol	O
___	O
PO	O
daily	O
and	O
indomethacin	O
50mg	O
PO	O
QID	O
PRN	O
gouty	O
attacks.	O
He	O
did	O
not	O
experience	O
any	O
gout	O
symptoms	O
during	O
this	O
admission.	O
.	O
>>	O
TRANSITIONAL	O
ISSUES:	O
#	O
Ischemic	O
CM,	O
decompenstaed	O
sCHF:	O
Patient	O
to	O
continue	O
home	O
torsemide	O
dose	O
for	O
maitnenace	O
diuresis.	O
He	O
is	O
to	O
continue	O
to	O
monitor	O
weights	O
and	O
low	O
sodium	O
diet.	O
#	O
___	O
PPM/ICD:	O
Patient	O
had	O
ICD	O
turned	O
OFF	O
during	O
admission	O
in	O
alliance	O
with	O
goals	O
of	O
care	O
discussion	O
during	O
hospital	O
stay	O
with	O
patient	O
and	O
patient's	O
family.	O
#	O
VT:	O
Patient	O
elected	O
to	O
have	O
withdrawal	O
of	O
milrinone	O
prior	O
to	O
discharge,	O
as	O
it	O
was	O
contributing	O
to	O
his	O
ectopy.	O
#	O
Code	O
Status:	O
Patient	O
has	O
elected	O
to	O
continue	O
DNR/DNI	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Allopurinol	O
___	O
mg	O
PO	O
DAILY	O
2.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
3.	O
Atorvastatin	O
80	O
mg	O
PO	O
DAILY	O
4.	O
Digoxin	O
0.125	O
mg	O
PO	O
DAILY	O
5.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID	O
6.	O
Finasteride	O
5	O
mg	O
PO	O
DAILY	O
7.	O
Levothyroxine	O
Sodium	O
137	O
mcg	O
PO	O
DAILY	O
8.	O
Lisinopril	O
2.5	O
mg	O
PO	O
DAILY	O
9.	O
Lorazepam	O
0.5	O
mg	O
PO	O
Q4H:PRN	O
anxiety	O
10.	O
Senna	O
8.6	O
mg	O
PO	O
BID	O
11.	O
Spironolactone	O
12.5	O
mg	O
PO	O
DAILY	O
12.	O
Tamsulosin	O
0.4	O
mg	O
PO	O
HS	O
13.	O
TraMADOL	O
(Ultram)	O
50	O
mg	O
PO	O
Q4H:PRN	O
pain	O
14.	O
TraZODone	O
100	O
mg	O
PO	O
HS	O
15.	O
Venlafaxine	O
XR	O
225	O
mg	O
PO	O
DAILY	O
16.	O
Torsemide	O
40	O
mg	O
PO	O
DAILY	O
17.	O
fenofibrate	O
145	O
mg	O
oral	O
daily	O
18.	O
Nitroglycerin	O
SL	O
0.4	O
mg	O
SL	O
PRN	O
chest	O
pain	O
19.	O
Indomethacin	O
50	O
mg	O
PO	O
QID:PRN	O
gout	O
20.	O
Hydrocodone-Acetaminophen	O
(5mg-325mg)	O
1	O
TAB	O
PO	O
Q4H:PRN	O
pain	O
21.	O
Nystatin	O
Cream	O
1	O
Appl	O
TP	O
BID	O
Discharge	O
Medications:	O
1.	O
Allopurinol	O
___	O
mg	O
PO	O
DAILY	O
2.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
3.	O
Atorvastatin	O
80	O
mg	O
PO	O
DAILY	O
4.	O
Digoxin	O
0.125	O
mg	O
PO	O
DAILY	O
5.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID	O
6.	O
Finasteride	O
5	O
mg	O
PO	O
DAILY	O
7.	O
Hydrocodone-Acetaminophen	O
(5mg-325mg)	O
1	O
TAB	O
PO	O
Q4H:PRN	O
pain	O
8.	O
Indomethacin	O
50	O
mg	O
PO	O
QID:PRN	O
gout	O
9.	O
Levothyroxine	O
Sodium	O
137	O
mcg	O
PO	O
DAILY	O
10.	O
Lorazepam	O
1.5	O
mg	O
PO	O
Q4H:PRN	O
anxiety	O
11.	O
Nitroglycerin	O
SL	O
0.4	O
mg	O
SL	O
PRN	O
chest	O
pain	O
12.	O
Nystatin	O
Cream	O
1	O
Appl	O
TP	O
BID	O
13.	O
Senna	O
8.6	O
mg	O
PO	O
BID	O
14.	O
Spironolactone	O
12.5	O
mg	O
PO	O
DAILY	O
15.	O
Tamsulosin	O
0.4	O
mg	O
PO	O
HS	O
16.	O
TraMADOL	O
(Ultram)	O
50	O
mg	O
PO	O
Q4H:PRN	O
pain	O
17.	O
TraZODone	O
100	O
mg	O
PO	O
HS	O
18.	O
Venlafaxine	O
XR	O
225	O
mg	O
PO	O
DAILY	O
19.	O
Torsemide	O
40	O
mg	O
PO	O
DAILY	O
20.	O
Amiodarone	O
400	O
mg	O
PO	O
BID	O
Duration:	O
7	O
Days	O
RX	O
*amiodarone	O
400	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
twice	O
a	O
day	O
Disp	O
#*14	O
Tablet	O
Refills:*0	O
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
Systolic	O
CHF	O
secondary	O
to	O
ischemic	O
cardiomyopathy	O
Primary:	O
Acute	O
on	O
chronic	O
systolic	O
HF,	O
ventricular	O
tachycardia	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
Dear	O
Mr.	O
___,	O
It	O
was	O
a	O
pleasure	O
caring	O
for	O
you	O
at	O
___	O
___.	O
You	O
were	O
admitted	O
after	O
a	O
right	O
heart	O
catheterization	O
showed	O
elevated	O
pressures	O
in	O
your	O
heart.	O
You	O
were	O
started	O
on	O
a	O
new	O
medication,	O
milrinone,	O
to	O
help	O
with	O
your	O
symptoms.	O
These	O
medications	O
will	O
not	O
be	O
continued	O
once	O
you	O
leave	O
the	O
hospital,	O
but	O
you	O
will	O
be	O
started	O
on	O
a	O
medication	O
to	O
suppress	O
abnormal	O
heart	O
rhythms.	O
It	O
is	O
very	O
important	O
to	O
limit	O
your	O
fluid	O
intake	O
to	O
less	O
than	O
2	O
liters	O
per	O
day	O
to	O
prevent	O
fluid	O
build	O
up.	O
You	O
should	O
also	O
limit	O
your	O
salt	O
intake	O
to	O
less	O
than	O
2g	O
per	O
day.	O
Please	O
weigh	O
yourself	O
every	O
morning,	O
and	O
call	O
your	O
MD	O
if	O
weight	O
goes	O
up	O
more	O
than	O
3	O
lbs.	O
We	O
are	O
glad	O
you	O
are	O
feeling	O
better	O
and	O
we	O
wish	O
you	O
well.	O
Your	O
___	O
team	O
Followup	O
Instructions:	O
___	O

